Close Menu

CHICAGO – Add IBM to the growing list of companies developing new information technology to expedite research into the novel SARS-CoV-2 coronavirus in hopes of finding treatments for COVID-19.

IBM Research said that it has been "actively developing" new cloud and artificial intelligence-based technologies to help researchers accelerate drug discovery and treatment in response to the COVID-19 pandemic. In collaboration with IBM Watson Health, the company has announced the free availability of a series of informatics tools in pursuit of answers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite sectretome, and more.

Sponsored by

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program.